Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI:10.1039/D0AN02286A
![Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI:10.1039/D0AN02286A](https://pubs.rsc.org/image/article/2021/AN/d0an02286a/d0an02286a-f15_hi-res.gif)
![](https://pubs.rsc.org/image/article/2021/AN/d0an02286a/d0an02286a-p1_hi-res.gif)
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
![](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.0c00054/asset/images/medium/mp0c00054_0009.gif)
A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus
![](https://pubs.rsc.org/image/article/2021/AN/d0an02286a/d0an02286a-f13_hi-res.gif)
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
![](https://pubs.rsc.org/image/article/2022/AN/d2an00703g/d2an00703g-f12_hi-res.gif)
Recent advances in antibiotic resistance diagnosis using SERS: focus on the “ Big 5 ” challenges - Analyst (RSC Publishing) DOI:10.1039/D2AN00703G
![](https://d3i71xaburhd42.cloudfront.net/601c8fdce02192f8b3150d23eae474ffbedccc36/16-Figure11-1.png)
PDF] Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40121-023-00815-z/MediaObjects/40121_2023_815_Fig2_HTML.png)
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
![](https://pubs.acs.org/cms/10.1021/acscentsci.8b00625/asset/images/medium/oc-2018-00625k_0003.gif)
From Point-of-Care Testing to eHealth Diagnostic Devices (eDiagnostics)
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00216-022-03918-7/MediaObjects/216_2022_3918_Figa_HTML.png)
Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic
![](https://d3i71xaburhd42.cloudfront.net/601c8fdce02192f8b3150d23eae474ffbedccc36/7-Figure3-1.png)
PDF] Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.
From Point-of-Care Testing to eHealth Diagnostic Devices (eDiagnostics)
![](https://pubs.rsc.org/image/article/2021/AN/d0an02286a/d0an02286a-p2_hi-res.gif)
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A